Alopexx
PrivateLast Round
IPO
Jun 26, 2026
Est. Valuation
$102M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Alopexx is a clinical-stage biotechnology company developing novel, broad-spectrum immune therapeutics for the prevention, treatment, and mitigation of bacterial, fungal, and parasitic infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alopexx Comparables
Compare Alopexx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Trellis Bioscience | 77% | |
| Bioversys | 76% | |
| Aridis Pharmaceuticals, Inc. | 75% | |
Alopexx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jun 26, 2026 | ||||
| Strategic | Sep 10, 2024 | ||||
| Strategic | Sep 6, 2024 |
Alopexx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bharat Biotech | Strategic |
| ThinkEquity | IPO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 26, 2026
$33M raised, led by ThinkEquity.
- Sep 10, 2024
Bharat Biotech participated in the strategic round.
Alopexx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alopexx's valuation, stock price, and market status.